Lysine

apolipoprotein A1 ; Homo sapiens







41 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35304099 The pattern of apolipoprotein A-I lysine carbamylation reflects its lipidation state and the chemical environment within human atherosclerotic aorta. 2022 Apr 2
2 34904415 ERα promotes transcription of tumor suppressor gene ApoA-I by establishing H3K27ac-enriched chromatin microenvironment in breast cancer cells. 2021 Dec 15 1
3 32900591 Glycation of HDL blunts its anti-inflammatory and cholesterol efflux capacities in vitro, but has no effect in poorly controlled type 1 diabetes subjects. 2020 Dec 1
4 29077935 Glycation Reduces the Stability of ApoAI and Increases HDL Dysfunction in Diet-Controlled Type 2 Diabetes. 2018 Feb 1 1
5 29155052 Characterization of covalent modifications of HDL apoproteins by endogenous oxidized phospholipids. 2018 Feb 1 1
6 30092227 Lysine glycation of apolipoprotein A-I impairs its anti-inflammatory function in type 2 diabetes mellitus. 2018 Sep 8
7 27487295 Fructated apolipoprotein A-I exacerbates cellular senescence in human umbilical vein endothelial cells accompanied by impaired insulin secretion activity and embryo toxicity. 2016 Aug 1
8 25170076 Definition of human apolipoprotein A-I epitopes recognized by autoantibodies present in patients with cardiovascular diseases. 2014 Oct 10 1
9 23454085 Apolipoprotein A-I binding to anionic vesicles and lipopolysaccharides: role for lysine residues in antimicrobial properties. 2013 Jun 3
10 23741493 Apolipoprotein A-I glycation by glucose and reactive aldehydes alters phospholipid affinity but not cholesterol export from lipid-laden macrophages. 2013 1
11 24308268 The conformation of lipid-free human apolipoprotein A-I in solution. 2013 Dec 31 2
12 21749932 Lysine residues of ABCA1 are required for the interaction with apoA-I. 2012 Mar 3
13 22178192 Site-specific oxidation of apolipoprotein A-I impairs cholesterol export by ABCA1, a key cardioprotective function of HDL. 2012 Mar 1
14 21501700 Impact of HDL oxidation by the myeloperoxidase system on sterol efflux by the ABCA1 pathway. 2011 Oct 19 1
15 20378541 Modifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway. 2010 Jun 11 4
16 18688016 Apolipoprotein A-I tryptophan substitution leads to resistance to myeloperoxidase-mediated loss of function. 2008 Nov 1
17 17216278 The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase. 2007 Mar 2
18 16495141 Apolipoprotein A-I lysine modification: effects on helical content, lipid binding and cholesterol acceptor activity. 2006 Jan 8
19 16497665 Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I. 2006 Apr 7 1
20 16774039 Pathways for oxidation of high-density lipoprotein in human cardiovascular disease. 2006 Jun 1
21 15723520 A three-dimensional molecular model of lipid-free apolipoprotein A-I determined by cross-linking/mass spectrometry and sequence threading. 2005 Mar 1 3
22 16037261 Acrolein modifies apolipoprotein A-I in the human artery wall. 2005 Jun 1
23 16126721 Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I. 2005 Oct 28 3
24 14660678 Lysine residues direct the chlorination of tyrosines in YXXK motifs of apolipoprotein A-I when hypochlorous acid oxidizes high density lipoprotein. 2004 Feb 27 2
25 12270762 Gene-drug interaction: additive influence of mutant APOA1 and testosterone on plasma HDL-cholesterol. 2002 Jul 1
26 11369801 Limited proteolysis of a disulfide-linked apoA-I dimer in reconstituted HDL. 2001 Jun 1
27 11689210 Recombinant proapoA-I(Lys107del) shows impaired lipid binding associated with reduced binding to plasma high density lipoprotein. 2001 Nov 3
28 10202375 In vivo kinetics of human apolipoprotein A-I variants in rabbits. 1999 Mar 3
29 9464251 Extensive intimal apolipoprotein A1-derived amyloid deposits in a patient with an apolipoprotein A1 mutation. 1998 Jan 26 1
30 9211897 The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein. 1997 Jul 11 1
31 7758222 Reactivity of lecithin-cholesterol acyl transferase (LCAT) towards glycated high-density lipoproteins (HDL). 1995 Jan 31 1
32 7890036 Native like structure and stability of apo AI in a n-propanol/water solution as determined by 13C NMR. 1995 Mar 13 2
33 8226847 Effect of cholesterol on the charge and structure of apolipoprotein A-I in recombinant high density lipoprotein particles. 1993 Nov 5 2
34 8467951 Interaction of N-methyl-anthraniloyl-labelled porcine apolipoprotein A-I with porcine lecithin: cholesterol acyltransferase: an energy transfer study. 1993 Apr 1
35 1464597 The conformation of apolipoprotein A-I in discoidal and spherical recombinant high density lipoprotein particles. 13C NMR studies of lysine ionization behavior. 1992 Dec 25 1
36 2123232 Comparison of deuterated leucine, valine, and lysine in the measurement of human apolipoprotein A-I and B-100 kinetics. 1990 Sep 2
37 3723016 Identification of homozygosity for a human apolipoprotein A-I variant. 1986 Apr 1
38 2986587 Characterization of a human hepatic receptor for high density lipoproteins. 1985 May-Jun 1
39 3929832 Effects of amino group modification in discoidal apolipoprotein A-I-egg phosphatidylcholine-cholesterol complexes on their reactions with lecithin:cholesterol acyltransferase. 1985 Jul 2 1
40 6432779 Abnormal lecithin:cholesterol acyltransferase activation by a human apolipoprotein A-I variant in which a single lysine residue is deleted. 1984 Aug 25 3
41 207344 Surface exposure of apolipoproteins in high density lipoproteins. I. Reactivities with agarose-immobilized proteases. 1978 May 25 1